Key takeaways:

Panel members said SSRI use during pregnancy has been tied to adverse fetal outcomes.

An expert told Healio the risks of untreated depression “is greater than the risks of SSRIs.”

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for depression during pregnancy, with some calling for stronger warning labels.

According to ACOG, about one in 10 pregnant women face depression, which can increase the risk for early labor, low birth weight and postnatal health complications.

An expert told Healio the risks of untreated depression “is greater than the risks of SSRIs.” Image: Adobe Stock

FDA Commissioner Martin Makary, MD, MPH, said SSRIs “can be an effective treatment for depression,” but he also said “se

See Full Page